{
    "clinical_study": {
        "@rank": "53504", 
        "acronym": "TRAP-My\u00e9line", 
        "arm_group": [
            {
                "arm_group_label": "Relapsing Multiple Sclerosis- group 1", 
                "arm_group_type": "Other", 
                "description": "Definite multiple sclerosis according to the McDonald criteria, relapsing Patient innocent of thorough treatment or treatment immunomodulator stopped for at least 6 months."
            }, 
            {
                "arm_group_label": "Relapsing Multiple Sclerosis- group 2", 
                "arm_group_type": "Other", 
                "description": "Multiple sclerosis defined according to the criteria of McDonald, relapsing Patient under treatment immunomodulator for at least 6 months."
            }, 
            {
                "arm_group_label": "secondary progressive multiple sclerosis- Group 3", 
                "arm_group_type": "Other", 
                "description": "Multiple sclerosis defined according to the criteria of McDonald, secondary progressive multiple sclerosis"
            }, 
            {
                "arm_group_label": "primary progressive multiple sclerosis- group 4", 
                "arm_group_type": "Other", 
                "description": "Multiple sclerosis defined according to the criteria of McDonald, primary progressive multiple sclerosis"
            }, 
            {
                "arm_group_label": "control 1", 
                "arm_group_type": "Other", 
                "description": "healthy volunteers"
            }, 
            {
                "arm_group_label": "Control 2", 
                "arm_group_type": "Other", 
                "description": "Patients with central or peripheral neurological non-inflammatory, non-autoimmune."
            }, 
            {
                "arm_group_label": "Control 3", 
                "arm_group_type": "Other", 
                "description": "Patients having an autoimmune pathology"
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of this project is to characterize the response TRAP positive patients with\n      Multiple Sclerosis (MS) and to evaluate the sensitivity and specificity of the method in\n      order to develop a second time as a diagnostic tool in this disease. We plan to analyze the\n      response TRAP over a hundred patients with various clinical stages SEP (relapsing,\n      progressive forms) and compared to healthy controls,"
        }, 
        "brief_title": "Analyze the Myelin-TRAP as Diagnostic Tool in Multiple Sclerosis", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Multiple Sclerosis", 
        "condition_browse": {
            "mesh_term": [
                "Multiple Sclerosis", 
                "Sclerosis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  These criteria depend on the subgroup belongs to the patient.\n\n          -  Signed consent\n\n          -  Membership of a social security system\n\n        Exclusion Criteria:\n\n          -  Whatever the patient group or control:\n\n          -  Processing immunosuppressive.\n\n          -  Processing by a monoclonal antibody.\n\n          -  Previous treatment with an immunosuppressant for a significant period of time (more\n             than 6 months of oral treatment, more than 6 cycles of cyclophosphamide   over 3\n             cures mitoxantrone).\n\n          -  Carcinomatous pathology known evolving.\n\n          -  People under guardianship.\n\n          -  Pregnant women.\n\n          -  Patients not motivated to study. Known patients with anemia (hemoglobin <10g/100ml)"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "55 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 6, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01723631", 
            "org_study_id": "10/06-S", 
            "secondary_id": "2010-A00892-37"
        }, 
        "intervention": {
            "arm_group_label": [
                "Relapsing Multiple Sclerosis- group 1", 
                "Relapsing Multiple Sclerosis- group 2", 
                "secondary progressive multiple sclerosis- Group 3", 
                "primary progressive multiple sclerosis- group 4", 
                "control 1", 
                "Control 2", 
                "Control 3"
            ], 
            "intervention_name": "Trap Myelin Test", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Multiple sclerosis", 
            "TRAP", 
            "TRAP-My\u00e9line"
        ], 
        "lastchanged_date": "April 29, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Bordeaux", 
                        "country": "France"
                    }, 
                    "name": "University Hospital of Bordeaux"
                }, 
                "investigator": {
                    "last_name": "Bruno Brochet, PU-PH", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bron", 
                        "country": "France"
                    }, 
                    "name": "Hopital neurologigue Pierre Wertheimer"
                }, 
                "investigator": {
                    "last_name": "Christian Confavreux, Pu-PH", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Clermont Ferrand", 
                        "country": "France"
                    }, 
                    "name": "University Hospital of clermont Ferrand"
                }, 
                "investigator": {
                    "last_name": "Pierre Clavelou, PU-PH", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lille", 
                        "country": "France"
                    }, 
                    "name": "University Hospital of Lille"
                }, 
                "investigator": {
                    "last_name": "Patrick Vermersch, PU-PH", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Marseille", 
                        "country": "France"
                    }, 
                    "name": "University Hospital of Marseille"
                }, 
                "investigator": {
                    "last_name": "Jean Pelletier, PU-PH", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montpellier", 
                        "country": "France"
                    }, 
                    "name": "University Hospital of Montpellier"
                }, 
                "investigator": {
                    "last_name": "William Camu, PU-PH", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nantes", 
                        "country": "France"
                    }, 
                    "name": "University Hospital of Nantes"
                }, 
                "investigator": [
                    {
                        "last_name": "David Laplaud, PH", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Mohamed Hamidou, PU-PH", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nice", 
                        "country": "France"
                    }, 
                    "name": "University Hospital of Nice"
                }, 
                "investigator": {
                    "last_name": "Christine Lebrun, PH", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rennes", 
                        "country": "France"
                    }, 
                    "name": "University Hospital of Rennes"
                }, 
                "investigator": {
                    "last_name": "Gilles Edan, PU-PH", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Strasbourg", 
                        "country": "France"
                    }, 
                    "name": "University Hospital of Strasbourg"
                }, 
                "investigator": {
                    "last_name": "Jer\u00f4me de Seze, Pu-PH", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toulouse", 
                        "country": "France"
                    }, 
                    "name": "University Hospital of Toulouse"
                }, 
                "investigator": {
                    "last_name": "Didier Brassat, PH", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "7", 
        "official_title": "Study Multicenter, Controlled, Prospective, Non-randomized Test to Analyze the Myelin-TRAP as Diagnostic Tool in Multiple Sclerosis", 
        "overall_contact": {
            "email": "david.laplaud@chu-nantes.fr", 
            "last_name": "David Laplaud, PH"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The main criterion corresponds to the area under the curve ROC (Receiver operating characteristic). The curve ROC is a graphic representation of the existing relation between the sensibility and the specificity of a test, calculated for all the values possible thresholds. The performance of the test TRAP-my\u00e9line will thus be estimated by means of the area calculated under this curve", 
            "measure": "Evaluate the diagnostic performance of myelin-TRAP assay for Multiple Sclerosis", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01723631"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Determine the best cut-off rate of myelin-Trap and evaluate the sensitivity and specificity associated", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "source": "Nantes University Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "Institut National de la Sant\u00e9 Et de la Recherche M\u00e9dicale, France", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Nantes University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2012", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}